SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-034147
Filing Date
2019-02-11
Accepted
2019-02-11 17:14:00
Documents
1
Group Members
CR GROUP L.P.CRG PARTNERS III (CAYMAN) UNLEV AIV I L.P.CRG PARTNERS LLL (CAYMAN) LEV AIV I L.P.CRG PARTNERS LLL - PARALLEL FUND A L.P.CRG PARTNERS LLL - PARALLEL FUND B (CAYMAN) L.P.CRG PARTNERS LLL L.P.IROKO PROPERTIES INC.NATHAN D. HUKILL

Document Format Files

Seq Description Document Type Size
1 SC 13D d709804dsc13d.htm SC 13D 193926
  Complete submission text file 0001193125-19-034147.txt   195892
Mailing Address GENEVA PLACE, WATERFRONT DRIVE P.O. BOX 3469 ROAD TOWN D8 VG1110
Business Address GENEVA PLACE, WATERFRONT DRIVE P.O. BOX 3469 ROAD TOWN D8 VG1110 267-546-3003
Iroko Pharmaceuticals Inc. (Filed by) CIK: 0001566717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Egalet Corp (Subject) CIK: 0001586105 (see all company filings)

IRS No.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87969 | Film No.: 19586486
SIC: 2834 Pharmaceutical Preparations